EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER

Perkovic V, Bain S, Bakris G, Buse J, Gondolf T, Idorn T, Lausvig N, Mahaffey K, Marso S, Nauck M, Pratley R, Rossing P, Zinman B, Mann J (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Nephrology Dialysis Transplantation Oxford University Press (OUP): Policy B

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: NEPHROLOGY DIALYSIS TRANSPLANTATION

Event location: Budapest

DOI: 10.1093/ndt/gfz106.fp482

Involved external institutions

Novo Nordisk A/S

Denmark (DK) AdventHealth

United States (USA) (US) University of North Carolina at Chapel Hill

United States (USA) (US) Steno Diabetes Center

Denmark (DK) University of Chicago Medical Center

United States (USA) (US) Ruhr-Universität Bochum (RUB)

Germany (DE) Stanford Medicine

United States (USA) (US) Swansea University

United Kingdom (GB) University of Toronto

Canada (CA) University of New South Wales (UNSW)

Australia (AU)

How to cite

APA:

Perkovic, V., Bain, S., Bakris, G., Buse, J., Gondolf, T., Idorn, T.,... Mann, J. (2019). EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER. In NEPHROLOGY DIALYSIS TRANSPLANTATION. Budapest, HU: OXFORD: OXFORD UNIV PRESS.

MLA:

Perkovic, Vlado, et al. "EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER." Proceedings of the 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest OXFORD: OXFORD UNIV PRESS, 2019.

BibTeX: Download